Safety and immunogenicity of an experimental live combination vaccine against enterovirus 71 and coxsackievirus A16 in rhesus monkeys

References

• Li YP, Liang ZL, Gao Q, Huang LR, Mao QY, Wen SQ, Liu Y, Yin WD, Li RC, Wang JZ. Safety and immunogenicity of a novel human enterovirus 71 (EV71) vaccine: a randomized, placebo-controlled, double-blind, phase I clinical trial. Vaccine. 2012;30:3295–303. doi:10.1016/j.vaccine.2012.03.010.
   PubMed Web of Science ®Google Scholar
• Zhu FC, Meng FY, Li JX, Li XL, Mao QY, Tao H, Zhang YT, Yao X, Chu K, Chen QH, et al. Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2013;381:2024–32. doi:10.1016/S0140-6736(13)61049-1.
   PubMed Web of Science ®Google Scholar
• Li R, Liu L, Mo Z, Wang X, Xia J, Liang Z, Zhang Y, Li Y, Mao Q, Wang J, et al. An inactivated enterovirus 71 vaccine in healthy children. N Engl J Med. 2014;370:829–37. doi:10.1056/NEJMoa1303224.
   PubMed Web of Science ®Google Scholar
• Yang T, Li H, Yue L, Song X, Xie T, Ma S, Meng H, Zhang Y, He X, Long R, et al. A comparative study of multiple clinical enterovirus 71 isolates and evaluation of cross protection of inactivated vaccine strain FY-23 K-B in vitro. Virol J. 2017;14:206. doi:10.1186/s12985-017-0872-8.
   PubMed Web of Science ®Google Scholar
• Zhang Y Study on the key technology of iyophilized experimental attenuated live attenuated vaccine of coxsackievirus A16[dissertation]. Chinese Academy of Medical Sciences & Peking Union Medical College; 2018. doi:10.3168/jds.2017-14085
   Google Scholar
• Yang SZ Attenuated characteristics and bioprocess assessment of CA16 vaccine candidates [dissertation]. Chinese Academy of Medical Sciences & Peking Union Medical College; 2015.
   Google Scholar
• Jiang GJ The selection of candidate strain of attenuated live coxsackievirus A16 vaccine [dissertation]. Chinese Academy of Medical Sciences & Peking Union Medical College; 2014. doi:10.1094/PDIS-06-14-0565-PDN
   Google Scholar
• Zhu F Development of EV71 live attenuated vaccines and the attenuation mechanism research [dissertation]. Chinese Academy of Medical Sciences & Peking Union Medical College; 2016.
   Google Scholar
• Zhang Y, Wang L, Liao Y, Liu L, Ma K, Yang E, Wang J, Che Y, Jiang L, Pu J, et al. Similar protective immunity induced by an inactivated enterovirus 71 (EV71) vaccine in neonatal rhesus macaques and children. Vaccine. 2015;33:6290–97. doi:10.1016/j.vaccine.2015.09.047.
   PubMed Web of Science ®Google Scholar
• Guo R, Cao YY, Dai ZZ, Qu SR, Zhuang JY. Characteristics of a human diploid cell line, KMB-17. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 1981;3:226–30.
   PubMedGoogle Scholar
• Mao JS, Dong DX, Zhang HY, Chen NL, Zhang XY, Huang HY, Xie RY, Zhou TJ, Wan ZJ, Wang YZ, et al. Primary study of attenuated live hepatitis A vaccine (H2 strain) in humans. J Infect Dis. 1989;159:621–24. doi:10.1093/infdis/159.4.621.
   PubMed Web of Science ®Google Scholar
• Liang Y, Che Y, Yang B, Zhan F, Li H, Guan X, Zhang Y, Yin Q, Li C, Li J, et al. Immunogenicity and safety of an F-genotype attenuated mumps vaccine in healthy 8- to 24-month-old children. J Infect Dis. 2019;219:50–58. doi:10.1093/infdis/jiy469.
   PubMed Web of Science ®Google Scholar
• Wang J, Zhang Y, Zhang X, Hu Y, Dong C, Liu L, Yang E, Che Y, Pu J, Wang X, et al. Pathologic and immunologic characteristics of coxsackievirus A16 infection in rhesus macaques. Virology. 2017;500:198–208. doi:10.1016/j.virol.2016.10.031.
   PubMed Web of Science ®Google Scholar
• Zhu FL, Li H, Xie TH, Yang T, Song X, Wang X, Shen D, Liu ZL, Yue L, Xie ZP. Dynamic changes of biological characteristics of EV-A71 strains continuously passaged in vitro at different temperatures. Chin J Viral Dis. 2016;6:113–18.
   Google Scholar
• Yang SZ, Xie TH, Li H, Jiang GJ, Long RX, Yang T, Yue L, Luo FY, Zhu FL, Xie ZP. Characteristics of live attenuated coxsackeivirus A16 candidate vaccine strain. Chin J Biol. 2015;28:441–48.
   Google Scholar
• Yang E, Cheng C, Zhang Y, Wang J, Che Y, Pu J, Dong C, Liu L, He Z, Lu S, et al. Comparative study of the immunogenicity in mice and monkeys of an inactivated CA16 vaccine made from a human diploid cell line. Hum Vaccin Immunother. 2014;10:1266–73. doi:10.4161/hv.28083.
   PubMed Web of Science ®Google Scholar
• Jiang GJ, Li H, Yang T, Liu ZL, Xie TH, Long RX, Yue L, Luo FY, Xie ZP. Biological characteristics of clinical isolates of coxsackievirus group A type 16. Chin J Biol. 2014;27:607–11.
   Google Scholar
• Dong C, Wang J, Liu L, Zhao H, Shi H, Zhang Y, Jiang L, Li Q. Optimized development of a candidate strain of inactivated EV71 vaccine and analysis of its immunogenicity in rhesus monkeys. Hum Vaccin. 2010;6:1028–37. doi:10.4161/hv.6.12.12982.
   PubMed Web of Science ®Google Scholar
• Zhongping X, Hua L, Ting Y, Zhengling L, Min F, Tianhong X, Runxiang L, Dong S, Guangju J, Lei Y, et al. Biological characteristics of different epidemic enterovirus 71 strains and their pathogeneses in neonatal mice and rhesus monkeys. Virus Res. 2016;213:82–89. doi:10.1016/j.virusres.2015.11.007.
   PubMed Web of Science ®Google Scholar
• Zhao T, Zhang Z, Zhang Y, Feng M, Fan S, Wang L, Liu L, Wang X, Wang Q, Zhang X, et al. Dynamic interaction of enterovirus 71 and dendritic cells in infected neonatal rhesus macaques. Front Cell Infect Microbiol. 2017;7:171. doi:10.3389/fcimb.2017.00171.
   PubMed Web of Science ®Google Scholar
• Wang J Study of Coxsackievirus A16-infected rhesus monkeys macaques model and immunologic characteristics [dissertation]. Chinese Academy of Medical Sciences & Peking Union Medical College, 2017.
   Google Scholar
• Qi SD, Wang JJ, Zhang XL, Shen F, Li QH, Li YY, Liu LD, He ZL. Study on proliferation of coxsackievirus A16-infected peripheral blood mononuclear cells in rhesus monkeys. J Microbes Infections(Chinese). 2015;10:140–46.
   Google Scholar
• Yamayoshi S, Yamashita Y, Li J, Hanagata N, Minowa T, Takemura T, Koike S. Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat Med. 2009;15:798–801. doi:10.1038/nm.1992.
   PubMed Web of Science ®Google Scholar
• Meng FY, Li JX, Li XL, Chu K, Zhang YT, Ji H, Li L, Liang ZL, Zhu FC. Tolerability and immunogenicity of an inactivated enterovirus 71 vaccine in Chinese healthy adults and children: an open label, phase 1 clinical trial. Hum Vaccin Immunother. 2012;8:668–74. doi:10.4161/hv.19521.
   PubMed Web of Science ®Google Scholar
• Liu D, Wu JH, Zhu QJ. The statistical analysis of laboratory examination of hand, foot and mouth diseases in wuhan city in 2009. J Mathe Med. 2011;24:565–67.
   Google Scholar
• Gao LZ, Li SJ, Zuo J, Tang L. Study on changes of electrocardiogram and biochemical indexes of 128 children with EV71 severe hand-foot-and mouth-disease. China Med Pharm. 2017;7:69–72.
   Google Scholar
• HZ Y, Chu C, Ji W, XD L, XH Z, BQ L, Xu J, WF Z. Analysis of 139 cases of hand, foot and mouth disease. J Pract Med. 2011;27:4469–70.
   Google Scholar
• Li M, Duan Y, Yang X, Yang Q, Pang B, Wang Y, Ren T, Wang X, Zhao Z, Liu S. Intradermal injection of a fractional dose of an inactivated HFMD vaccine elicits similar protective immunity to intramuscular inoculation of a full dose of an Al(OH)3-adjuvanted vaccine. Vaccine. 2017;35:3709–17. doi:10.1016/j.vaccine.2017.05.060.
   PubMed Web of Science ®Google Scholar
• Mamik MK, Ghorpade A. CXCL8 as a potential therapeutic target for HIV-associated neurocognitive disorders. Curr Drug Targets. 2016;17:111–21. doi:10.2174/1389450116666150626124544.
   PubMed Web of Science ®Google Scholar
• Wang SM, Lei HY, Huang KJ, Wu JM, Wang JR, Yu CK, Su IJ, Liu CC. Pathogenesis of enterovirus 71 brainstem encephalitis in pediatric patients: roles of cytokines and cellular immune activation in patients with pulmonary edema. J Infect Dis. 2003;188:564–70. doi:10.1086/376998.
   PubMed Web of Science ®Google Scholar
• Ye N, Gong X, Pang LL, Gao WJ, Zhang YT, Li XL, Liu N, Li DD, Jin Y, Duan ZJ. Cytokine responses and correlations thereof with clinical profiles in children with enterovirus 71 infections. BMC Infect Dis. 2015;15:225. doi:10.1186/s12879-015-0965-1.
   PubMed Web of Science ®Google Scholar
• Kew OM, Wright PF, Agol VI, Delpeyroux F, Shimizu H, Nathanson N, Pallansch MA. Circulating vaccine-derived polioviruses: current state of knowledge. Bull World Health Organ. 2004;82:16–23.
   PubMed Web of Science ®Google Scholar
• Yip CCY, Lau SKP, Woo PCY, Yuen K-Y. Human enterovirus 71 epidemics: what’s next? Emerg Health Threats J. 2013;6:19780–19780. doi:10.3402/ehtj.v6i0.19780.
   PubMedGoogle Scholar
• Mandary MB, Poh CL. Changes in the EV-A71 genome through recombination and spontaneous mutations: impact on virulence. Viruses. 2018;10:320. doi:10.3390/v10060320.
   PubMed Web of Science ®Google Scholar